The FDA Breakthrough-Drug Designation — Four Years of Experience

In 2012, Congress created the "breakthrough therapy" designation to expedite Food and Drug Administration (FDA) testing and approval of medications that were intended to treat serious or life-threatening conditions and that preliminary evidence suggested may provide a substantial improvement over…

https://ift.tt/2HtDhI7